Shire Pharmaceuticals Acquires SARCode Bioscience for $160,000,000

  • Feed Type
  • Date
  • Company Name
    SARCode Bioscience
  • Mailing Address
    1000 Marina Boulevard Brisbane, CA 94005
  • Company Description
    SARcode is a private company focused on the development of small molecule LFA-1 inhibitors to treat inflammatory diseases.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    In addition to the upfront payment of $160 million, shareholders in California-based SARcode will be eligible for additional undisclosed payments upon achievement of certain drug development and commercial milestones.